We share our knowledge and insights about industry trends and market developments in pharmaceutical product life cycle management.

A brand team had to develop a marketing plan leading up to a product’s loss of exclusivity. Most of the brand team and field force were disbanded and the marketing budget for the brand was significantly decreased. How…

A well-known pharmaceutical drug with six indications, received multiple safety label updates within one year. The changes to the label impacted the Important Safety Information, which in turn required updating of each indication’s marketing materials (print and digital).…

BENEFITS OF CENTRALIZING THE LABEL UPDATE PROCESS ACROSS AN ORGANIZATION Pharmaceutical marketing departments that centralize and standardize their approach to required label/Important Safety Information (ISI) updates, including the advance planning of upcoming labeling changes and continued optimization of their internal…

EFFICENTLY MANAGING REVISIONS TO MARKETING MATERIALS At any time during the active marketing of a pharmaceutical product, there is a high probability of having to implement a safety label update, impacting the Important Safety Information (ISI) that is highlighted in…

When the U.S. Oncology team of a global pharmaceutical company were ready to execute on the vision of industry-leading engagement, they looked to CMK to help them translate it with structured change management. Healthcare providers were receiving massive…

A Client’s Life Sciences data analytics team was seeking to gain foundational knowledge of project management.  The team’s existing work environment centered around rapid response to their internal clients. The result was frequent scope creep, dissatisfied clients, and…

A privately owned, rapidly growing pharmaceutical company was charged with rolling out 22 releases for a multi-product launch in one year’s time. In the early stages of the program, the client struggled with a series of issues that,…

The U.S. cardiovascular team of a global pharmaceutical company needed help responding to a new Corporate Integrity Agreement for two launch products. Resource-constrained at the time, they were looking for a streamlined and efficient way to satisfy the…

Within hematology, Higher Risk-Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia (AML) are diseases with a highly unmet treatment need. In response, an NJ-based pharmaceutical leader created an innovative new immune-modulating treatment that shows tremendous promise in the fight…

When two large pharmaceutical companies merged, the study teams struggled with a lack of clarity over which operating models to follow for their respective studies. With heritage procedures and IT systems in place across both entities, and pros…

Project management challenges exist at all levels of the organization—from the highest strategic level down to the project task level. In today’s business environment, an organization’s ability to recognize and resolve those challenges is a crucial driver in enhancing business…

CMK Select is pleased to announced that it has been recognized by NJBIZ as a finalist for 2020 Business of the Year. Each year, NJBIZ recognizes the state’s most dynamic businesses and business leaders who share a commitment to professional…